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Background: Deliberative, experiential and affective risk perceptions independently predict health 
behaviours. Inconsistent evidence suggests individuals reporting high deliberative risk and high 
affective risk may be less likely to take preventive health actions than those reporting lower 
perceived risk on either scale. Within-subject stability in perceived risk is also largely unexplored. We 
examined these associations in a cohort of women at high risk of breast cancer making decisions 
about preventive therapy.  
Methods: We approached 732 women at 20 UK hospitals to complete a survey following an 
appointment to discuss their breast cancer risk. Within the appointment, the option of taking 
tamoxifen as a prophylactic was discussed. Surveys were returned by 407/732 (55.7%) women, and 
258 (63.2%) provided data at 3-months. Baseline measures included deliberative risk (‘compared 
with women my age, my chances of breast cancer are…’), experiential risk, (‘I feel vulnerable to 
getting breast cancer’), and affective risk (‘In the past 7 days I worried about developing breast 
cancer’). Measures were repeated at 3-months and self-reported uptake of tamoxifen was also 
recorded.  
Results: Deliberative (M=3.02 out of 5, SD=0.66), experiential (M=3.13 out of 4, SD=0.72) and 
affective risk (M=2.69 out of 4, SD=0.95) were elevated at baseline. Women reporting higher 
experiential risk perception were more likely to report higher deliberative (r=0.20, p<0.01) and 
affective (r=0.42, p<0.01) risk perceptions. There was no relationship between deliberative risk and 
affective risk. In a model adjusted for demographics, women reporting higher deliberative risk had a 
non-significant increased likelihood of reporting tamoxifen use at 3-months (OR=2.17, 95%CI=0.98-
4.79). There was no association between either experiential risk or affective risk and tamoxifen 
uptake. There were no 2-way interactions between the perceived risk items on uptake of tamoxifen. 
Respondents reported different affective risk scores between baseline and 3-months (p ≤ 0.001); 
with a greater likelihood of their affective risk declining than increasing. There were no differences in 
experiential or deliberative perceived risk between baseline and follow-up.  
Conclusions: The tririsk model components were related to each other, but only deliberative risk 
affected preventive therapy decision-making. Data on components of perceived risk collected in the 
general population may not generalise to high risk groups.  
 
